Guided Therapeutics

Guided Therapeutics Current Assets

The Current Assets of Guided Therapeutics (GTHP) as of Oct 25, 2026 is 538,000.00 USD. In the previous year, Current Assets was 809,000.00 USD — a change of -33.50% (lower).

Current Assets

538,000.00USD

YoY

-33.50%

Last updated:

Current Assets of Guided Therapeutics is 2025 538,000.00 USD. Current Assets of Guided Therapeutics was 2024 809,000.00 USD. It decreases by -33.50% lower compared to the previous year.

The Guided Therapeutics Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
193,000.00 USD
Jan 1, 2019
128,000.00 USD
Jan 1, 2020
710,000.00 USD
Jan 1, 2021
998,000.00 USD
Jan 1, 2022
695,000.00 USD
Jan 1, 2023
802,000.00 USD
Jan 1, 2024
809,000.00 USD
Jan 1, 2025
538,000.00 USD
The Guided Therapeutics Current Assets history
YEARCurrent AssetsYoY
538,000.00USD-33.50%
809,000.00USD+0.87%
802,000.00USD+15.40%
695,000.00USD-30.36%
998,000.00USD+40.56%
710,000.00USD+454.69%
128,000.00USD-33.68%
193,000.00USD-34.13%
293,000.00USD-71.83%
1.04 MUSD-51.17%
2.13 MUSD+19.66%
1.78 MUSD-12.32%
2.03 MUSD+8.56%
1.87 MUSD-35.29%
2.89 MUSD-14.75%
3.39 MUSD+726.83%
410,000.00USD+46.43%
280,000.00USD+47.37%
190,000.00USD-69.35%
620,000.00USD-45.61%
1.14 MUSD-46.98%
2.15 MUSD-20.37%
2.70 MUSD-10.00%
3.00 MUSD-74.00%
11.54 MUSD+101.40%
5.73 MUSD-9.48%
6.33 MUSD+2.76%
6.16 MUSD-53.82%
13.34 MUSD+177.34%
4.81 MUSD+1,274.29%
350,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Guided Therapeutics Stock analysis

What does Guided Therapeutics do? Guided Therapeutics, Inc. develops medical devices focused on cancer detection using biophotonics. The company's primary product is the LuViva Advanced Cervical Scan, a non-invasive device for cervical cancer screening and triage. LuViva analyzes reflected and fluorescent light after scanning the cervix with light, offering an alternative to conventional tests. The firm targets healthcare providers and clinics seeking point-of-care solutions for cervical cancer detection. LuViva is designed for two main applications: as a screening tool for early detection of cervical cancer and precancers, and as a triage method to reduce unnecessary follow-up procedures. The company focuses on selling and marketing this device to medical facilities, emphasizing its painless, non-invasive nature and point-of-care functionality. Guided Therapeutics conducts limited clinical studies using its biophotonic technology to support the device's efficacy. The business model centers on the commercialization of LuViva, with the company developing prototypes and conducting clinical studies to validate its biophotonic detection method. Guided Therapeutics aims to position LuViva as a standard in cervical cancer screening, targeting healthcare providers who prioritize non-invasive, efficient diagnostic tools. The firm's revenue comes from the sale of LuViva devices and related services to medical institutions. Guided Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Guided Therapeutics stock

Current Assets of Guided Therapeutics is 538,000.00 USD in 2025.

Current Assets of Guided Therapeutics changed from 809,000.00 USD to 538,000.00 USD, representing a -33.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Guided Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Guided Therapeutics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Guided Therapeutics

All Key Metrics — Guided Therapeutics